P hili ps Me dical Sy stems
5 Clinical and Safety Considerations
Clinical Considerations
Indications
The HeartStart FR2+ is indicated for use on victims of sudden cardiac arrest exhibiting the following signs:
Unresponsiveness
Absence of normal breathing
The HeartStart FR2+ is intended for use by personnel who have been trained in its operation. The user should be qualified by training in basic life support, advanced life support, or other
N O T E : At the discretion of emergency care personnel, the M3860A FR2+ |
|
with ECG display enabled can also be used with the FR2+ ECG |
|
assessment module to display the rhythm of a responsive or breathing |
|
patient, regardless of age. There are no known contraindications to use of |
|
the FR2+ ECG assessment module. | 5 |
Contraindications
The HeartStart FR2+ is contraindicated for use (should not be used) on patients who show either of the following signs:
Responsiveness
Presence of normal breathing
Safety Considerations
You should be aware of the safety concerns listed here when you use the HeartStart FR2+. Read them carefully. You will also see some of these messages in other parts of this manual. The messages are labeled Danger, Warning, or Caution.
D A N G E R — immediate hazards that will result in personal injury or death.
W A R N I N G — conditions, hazards, or unsafe practices that can result in serious personal injury or death.
